496
Views
116
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden

, PhD , MD, , &
Pages 1095-1101 | Received 11 Oct 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Tao Sun, Shilin Xiao, Miaomiao Wang, Qian Xie, Liang Zhang, Mingfu Gong, Dong Zhang & Chunyu Zhou. (2023) Reactive Oxygen Species Scavenging Nanozymes: Emerging Therapeutics for Acute Liver Injury Alleviation. International Journal of Nanomedicine 18, pages 7901-7922.
Read now
M. Vitrone, F. Mele, E. Durante-Mangoni & R. Zampino. (2022) Drugs and liver injury: a not to be overlooked binomial in COVID-19. Journal of Chemotherapy 34:4, pages 207-220.
Read now
Miren García-Cortés, Aida Ortega-Alonso, M. Isabel Lucena & Raúl J. Andrade. (2018) Drug-induced liver injury: a safety review. Expert Opinion on Drug Safety 17:8, pages 795-804.
Read now
Einar S. Björnsson. (2017) Drug-induced liver injury due to antibiotics. Scandinavian Journal of Gastroenterology 52:6-7, pages 617-623.
Read now
Jonathan G. Stine & Patrick G. Northup. (2016) Autoimmune-like drug-induced liver injury: a review and update for the clinician. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1291-1301.
Read now
Jonathan G. Stine & James H. Lewis. (2016) Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Review of Gastroenterology & Hepatology 10:4, pages 517-536.
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
Jonathan G Stine & James H Lewis. (2011) Drug-induced liver injury: a summary of recent advances. Expert Opinion on Drug Metabolism & Toxicology 7:7, pages 875-890.
Read now
José AG Agúndez, María Isabel Lucena, Carmen Martínez, Raúl J Andrade, Miguel Blanca, Pedro Ayuso & Elena García-Martín. (2011) Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology 7:7, pages 817-828.
Read now
C-J Törnhage, G Brunlöf & S M Wallerstedt. (2009) Severe hepatotoxic adverse reaction in a healthy schoolgirl after treatment with flucloxacillin. Drug, Healthcare and Patient Safety 1, pages 17-19.
Read now
Raúl J Andrade, Susana López-Ortega, Mª Carmen López-Vega, Mercedes Robles, Ignacio Cueto & Mª Isabel Lucena. (2008) Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Review of Clinical Pharmacology 1:2, pages 261-276.
Read now
S Hyder Hussaini & Elizabeth A Farrington. (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opinion on Drug Safety 6:6, pages 673-684.
Read now

Articles from other publishers (103)

Marta Moreno-Torres, Ernesto López-Pascual, Anna Rapisarda, Guillermo Quintás, Annika Drees, Inger-Lise Steffensen, Thomas Luechtefeld, Eva Serrano-Candelas, Marina Garcia de Lomana, Domenico Gadaleta, Hubert Dirven, Mathieu Vinken & Ramiro Jover. (2024) Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support. Biomedicine & Pharmacotherapy 174, pages 116530.
Crossref
Miren García-Cortés, Juan Pedro Toro-Ortiz & Alberto García-García. (2023) Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review. Exploration of Digestive Diseases, pages 318-336.
Crossref
Qian Wei, Lei Li, Xiaoqing Zeng, Jie Yin & Jinsheng Guo. (2023) An analysis on the clinical features and risk factors associated with the prognosis of patients with drug-induced liver injury. Exploration of Digestive Diseases, pages 100-117.
Crossref
Chunyu Zhou, Liang Zhang, Zhongsheng Xu, Tao Sun, Mingfu Gong, Yun Liu & Dong Zhang. (2023) Self‐Propelled Ultrasmall AuNPs‐Tannic Acid Hybrid Nanozyme with ROS‐Scavenging and Anti‐Inflammatory Activity for Drug‐Induced Liver Injury Alleviation. Small 19:19.
Crossref
Rosane Christine Hahn, Ferry Hagen, Rinaldo Poncio Mendes, Eva Burger, Andreia Ferreira Nery, Nathan Pereira Siqueira, Armando Guevara, Anderson Messias Rodrigues & Zoilo Pires de Camargo. (2022) Paracoccidioidomycosis: Current Status and Future Trends. Clinical Microbiology Reviews 35:4.
Crossref
Xiaoping Shi, Donghui Lao, Qing Xu, Xiaoyu Li & Qianzhou Lv. (2022) A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infectious Diseases 22:1.
Crossref
Kailey Tang, Stefan Coombs & Amanda Gwee. (2022) Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins. Journal of Antimicrobial Chemotherapy 77:12, pages 3221-3230.
Crossref
Chin Kimg Tan, Danielle Ho, Lai Mun Wang & Rahul Kumar. (2022) Drug-induced autoimmune hepatitis: A minireview. World Journal of Gastroenterology 28:24, pages 2654-2666.
Crossref
Marta Moreno-Torres, Guillermo Quintás & José V. Castell. (2022) The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment. Metabolites 12:6, pages 564.
Crossref
Farzin Zobdeh, Ivan I. Eremenko, Mikail A. Akan, Vadim V. Tarasov, Vladimir N. Chubarev, Helgi B. Schiöth & Jessica Mwinyi. (2022) Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review. Pharmaceutics 14:6, pages 1190.
Crossref
Chunyan Wei, Ying Liu, Aidou Jiang & Bin Wu. (2022) A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data. International Journal of Clinical Pharmacy 44:3, pages 709-716.
Crossref
Einar S. Björnsson, Vesna Vucic, Guido Stirnimann & Mercedes Robles-Díaz. (2022) Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review. Frontiers in Pharmacology 13.
Crossref
Mohamed Kadry Taher, James A G Crispo, Yannick Fortin, Ryan Moog, Douglas McNair, Lise M Bjerre, Franco Momoli, Donald Mattison & Daniel Krewski. (2021) Systemic quinolones and risk of acute liver failure III: A nested case–control study using a US electronic health records database. Journal of Gastroenterology and Hepatology 36:8, pages 2307-2314.
Crossref
Mei‐An Middelkoop, Pierre M. Bet, Joost P.H. Drenth, Judith A.F. Huirne & Wouter J.K. Hehenkamp. (2021) Risk–efficacy balance of ulipristal acetate compared to surgical alternatives. British Journal of Clinical Pharmacology 87:7, pages 2685-2697.
Crossref
Jisue Lee, Jae-Goo Kim, Haena Lee, Tae Hoon Lee, Ki-Young Kim & Hakwon Kim. (2021) Antifungal Activity of 1,4-Dialkoxynaphthalen-2-Acyl Imidazolium Salts by Inducing Apoptosis of Pathogenic Candida spp.. Pharmaceutics 13:3, pages 312.
Crossref
Yi‐Ju Li, Elizabeth J. Phillips, Andrew Dellinger, Paola Nicoletti, Ryan Schutte, Danmeng Li, David A. Ostrov, Robert J. Fontana, Paul B. Watkins, Andrew Stolz, Ann K Daly, Guruprasad P Aithal, Huiman Barnhart & Naga Chalasani. (2021) Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury. Hepatology 73:1, pages 268-281.
Crossref
Oleg S. Tkachenko, Luana V. Souza, Monique Deon, Emilene M. Becker, Eliana W. de Menezes, Leliz T. Arenas & Edilson V. Benvenutti. (2020) AgNP‐decorated SBA‐15 for MWCNT Paste Modified Electrode: A Sensor for Simultaneous Voltammetric Determination of Paracetamol and Sulfamethoxazole. Electroanalysis 33:1, pages 29-37.
Crossref
Rodrigo M. Burgos, Kate M. ReynoldsJean WilliamsWenchin LiConnie H. Yan. (2020) Trimethoprim-Sulfamethoxazole Associated Drug-Induced Liver Injury in Pediatrics: A Systematic Review. Pediatric Infectious Disease Journal 39:9, pages 824-829.
Crossref
L. B. Lazebnik, E. V. Golovanova, O. V. Hlynova, S. A. Alekseenko, O. I. Aryamkina, I. G. Bakulin, N. V. Bakulina, A. Yu. Baranovsky, O. A. Bondarenko, A. N. Varganova, T. V. VolkovaL. G. Vologzhanina, I. A. Volchegorsky, T. P. Demicheva, A. I. Dolgushina, I. V. Mayev, O. N. Minushkin, K. I. Raykhelson, E. N. Smirnova, L. V. Tarasova & Yu. V. Tsyganova. (2020) Medicinal liver damage in adults. Experimental and Clinical Gastroenterology 174:2, pages 29-54.
Crossref
Naemat Sandhu & Victor Navarro. (2020) Drug‐Induced Liver Injury in GI Practice. Hepatology Communications 4:5, pages 631-645.
Crossref
Paul A Schmeltzer. (2019) Drug-Induced Liver Injury Due to Nonsteroidal Anti-inflammatory Drugs. Current Hepatology Reports 18:3, pages 294-299.
Crossref
Einar S. Björnsson. (2019) Global Epidemiology of Drug-Induced Liver Injury (DILI). Current Hepatology Reports 18:3, pages 274-279.
Crossref
Paola Nicoletti, Guruprasad P. Aithal, Thomas C. Chamberlain, Sally Coulthard, Mohammad Alshabeeb, Jane I. Grove, Raul J. Andrade, Einar Bjornsson, John F. Dillon, Par Hallberg, M. Isabel Lucena, Anke H. Maitland‐van der Zee, Jennifer H. Martin, Mariam Molokhia, Munir Pirmohamed, Mia Wadelius, Yufeng Shen, Matthew R. Nelson & Ann K. Daly. (2019) Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles. Clinical Pharmacology & Therapeutics 106:1, pages 245-253.
Crossref
Tao Shen, Yingxia Liu, Jia Shang, Qing Xie, Jun Li, Ming Yan, Jianming Xu, Junqi Niu, Jiajun Liu, Paul B. Watkins, Guruprasad P. Aithal, Raúl J. Andrade, Xiaoguang Dou, Lvfeng Yao, Fangfang Lv, Qi Wang, Yongguo Li, Xinmin Zhou, Yuexin Zhang, Peilan Zong, Bin Wan, Zhengsheng Zou, Dongliang Yang, Yuqiang Nie, Dongliang Li, Yuya Wang, Xi’an Han, Hui Zhuang, Yimin Mao & Chengwei Chen. (2019) Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology 156:8, pages 2230-2241.e11.
Crossref
Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Dominique Larrey & Tom H. Karlsen. (2019) EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology 70:6, pages 1222-1261.
Crossref
Ching-Feng Weng & Max K. Leong. 2019. 31 68 .
Alexander Brack & Michael Schäfer. 2019. Die Anästhesiologie. Die Anästhesiologie 315 342 .
Yunn-Fang Ho, Hsin-Ying Chou, Jan-Show Chu & Ping-Ing Lee. (2018) Comedication with interacting drugs predisposes amiodarone users in cardiac and surgical intensive care units to acute liver injury. Medicine 97:37, pages e12301.
Crossref
Rosa A. Luirink, Stefan J. Dekker, Luigi Capoferri, Laura F.H. Janssen, Cynthia L. Kuiper, Mehmet E. Ari, Nico P.E. Vermeulen, J. Chris Vos, Jan N.M. Commandeur & Daan P. Geerke. (2018) A combined computational and experimental study on selective flucloxacillin hydroxylation by cytochrome P450 BM3 variants. Journal of Inorganic Biochemistry 184, pages 115-122.
Crossref
Arul M. Thomas & James H. Lewis. (2018) Nonacetaminophen Drug-Induced Acute Liver Failure. Clinics in Liver Disease 22:2, pages 301-324.
Crossref
Kevin N. Woodward. 2018. Regulatory Toxicology in the European Union. Regulatory Toxicology in the European Union 163 242 .
Pavan K. Mukthinuthalapati, Robert J. Fontana, Raj Vuppalanchi, Naga Chalasani & Marwan Ghabril. (2018) Celecoxib-induced Liver Injury. Journal of Clinical Gastroenterology 52:2, pages 114-122.
Crossref
David E. Kleiner. 2018. Practical Hepatic Pathology: a Diagnostic Approach. Practical Hepatic Pathology: a Diagnostic Approach 327 370 .
Harshad Devarbhavi, Herbert L. Bonkovsky, Mark Russo & Naga Chalasani. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 844 890.e17 .
Harshad Devarbhavi. (2017) Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management. Current Hepatology Reports 16:4, pages 276-285.
Crossref
Dominique Larrey, Jose Ursic‐Bedoya & Lucy Meunier. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver 740 773 .
Vinay Sundaram & Einar S. Björnsson. (2017) Drug‐induced cholestasis. Hepatology Communications 1:8, pages 726-735.
Crossref
He Tingting, Zhu Yun, Wang Jiabo, Gong Man, Wang Ruilin, Niu Ming, Jing Jing, Wang Lifu, Wang Zhongxia, Zhang Ning, Bai Zhaofang, Bai Yunfeng, Li Yonggang & Xiao Xiaohe. (2017) Clinical characteristics of 96 patients with drug-induced acute liver failure: a comparison between Traditional Chinese and Western Medicine. Journal of Traditional Chinese Medicine 37:3, pages 286-297.
Crossref
Yue-cheng Yu, Yi-min Mao, Cheng-wei Chen, Jin-jun Chen, Jun Chen, Wen-ming Cong, Yang Ding, Zhong-ping Duan, Qing-chun Fu, Xiao-yan Guo, Peng Hu, Xi-qi Hu, Ji-dong Jia, Rong-tao Lai, Dong-liang Li, Ying-xia Liu, Lun-gen Lu, Shi-wu Ma, Xiong Ma, Yue-min Nan, Hong Ren, Tao Shen, Hao Wang, Ji-yao Wang, Tai-ling Wang, Xiao-jin Wang, Lai Wei, Qing Xie, Wen Xie, Chang-qing Yang, Dong-liang Yang, Yan-yan Yu, Min-de Zeng, Li Zhang, Xin-yan Zhao & Hui Zhuang. (2017) CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatology International 11:3, pages 221-241.
Crossref
Jonathan G. Stine & Naga P. Chalasani. (2017) Drug Hepatotoxicity. Clinics in Liver Disease 21:1, pages 103-113.
Crossref
Sandra Doß, Heike Potschka, Fanny Doß, Steffen Mitzner & Martin Sauer. (2017) Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results. BioMed Research International 2017, pages 1-10.
Crossref
Wen-Lang Fan, Meng-Shin Shiao, Rosaline Chung-Yee Hui, Shih-Chi Su, Chuang-Wei Wang, Ya-Ching Chang & Wen-Hung Chung. (2017) HLA Association with Drug-Induced Adverse Reactions. Journal of Immunology Research 2017, pages 1-10.
Crossref
Chei Won Kim, Ji Sun Park, Se Hwan Oh, Jae-Hyung Park, Hyun-Ik Shim, Jae Woong Yoon, Jin Seok Park, Seong Bin Hong, Jun Mi Kim, Trong Binh Le & Jin Woo Lee. (2016) Drug-induced liver injury caused by iodine-131. Clinical and Molecular Hepatology 22:2, pages 272-275.
Crossref
Paul A. Schmeltzer, Andrzej S. Kosinski, David E. Kleiner, Jay H. Hoofnagle, Andrew Stolz, Robert J. Fontana & Mark W. Russo. (2015) Liver injury from nonsteroidal anti‐inflammatory drugs in the United States. Liver International 36:4, pages 603-609.
Crossref
Einar S. Björnsson & Jay H. Hoofnagle. (2015) Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports. Hepatology 63:2, pages 590-603.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 176 200 .
Alexander Brack & Michael Schäfer. 2017. Die Anästhesiologie. Die Anästhesiologie 1 28 .
William M. Lee. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1958 1972 .
Jonathan G. Stine & Naga Chalasani. (2015) Chronic liver injury induced by drugs: a systematic review. Liver International 35:11, pages 2343-2353.
Crossref
V. L. M. Yip, A. Alfirevic & M. Pirmohamed. (2014) Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review. Clinical Reviews in Allergy & Immunology 48:2-3, pages 165-175.
Crossref
Victoria Kegel, Elisa Pfeiffer, Britta Burkhardt, Jia L. Liu, Katrin Zeilinger, Andreas K. Nüssler, Daniel Seehofer & Georg Damm. (2015) Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a Human In Vitro Liver Model: An Approach to Study DILI . Mediators of Inflammation 2015, pages 1-14.
Crossref
A. Wiebrecht & A. Kalg. (2014) Letter: herbal hepatotoxicity – an update on traditional Chinese medicine preparations. Alimentary Pharmacology & Therapeutics 40:6, pages 737-738.
Crossref
Lauren Walker, Vincent Yip & Munir Pirmohamed. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine 405 435 .
B.S. Apica & W.M. Lee. 2014. Pathobiology of Human Disease. Pathobiology of Human Disease 1825 1837 .
Casey Lynnette Overby, Jyotishman Pathak, Omri Gottesman, Krystl Haerian, Adler Perotte, Sean Murphy, Kevin Bruce, Stephanie Johnson, Jayant Talwalkar, Yufeng Shen, Steve Ellis, Iftikhar Kullo, Christopher Chute, Carol Friedman, Erwin Bottinger, George Hripcsak & Chunhua Weng. (2013) A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. Journal of the American Medical Informatics Association 20:e2, pages e243-e252.
Crossref
Alberto Unzueta & Hugo E. Vargas. (2013) Nonsteroidal Anti-Inflammatory Drug–Induced Hepatoxicity. Clinics in Liver Disease 17:4, pages 643-656.
Crossref
Einar S. Bjornsson & Jon Gunnlaugur Jonasson. (2013) Drug-Induced Cholestasis. Clinics in Liver Disease 17:2, pages 191-209.
Crossref
Marija Petronijevic & Katarina Ilic. (2013) Associations of Gender and Age with the Reporting of Drug‐Induced Hepatic Failure: Data from the VigiBase™. The Journal of Clinical Pharmacology 53:4, pages 435-443.
Crossref
Martin Blachier, Henri Leleu, Markus Peck-Radosavljevic, Dominique-Charles Valla & Françoise Roudot-Thoraval. (2013) The burden of liver disease in Europe: A review of available epidemiological data. Journal of Hepatology 58:3, pages 593-608.
Crossref
Somnath Mondal, Saibal Das, Sanjib Bandyopadhyay, Ankur Datta, Souvik Sardar, Pradip Kumar Ghosal & Santanu Kumar Tripathi. (2013) Hepatotoxicity of atenolol therapy - A report of 2 cases. Journal of Acute Disease 2:3, pages 246-249.
Crossref
Richard H. Moseley. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease 463 481 .
Dominique Larrey & Marie-Pierre Ripault. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease 443 462 .
James H. Lewis & Jonathan G. Stine. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease 369 401 .
Kevin Woodward & Kevin WoodwardK. N. Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans 117 149 .
Kevin Woodward & Kevin WoodwardK. N Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans 81 116 .
Feng-Qin Hou, Zheng Zeng & Gui-Qiang Wang. (2012) Hospital Admissions for Drug-Induced Liver Injury: Clinical Features, Therapy, and Outcomes. Cell Biochemistry and Biophysics 64:2, pages 77-83.
Crossref
Nicola J Gullick & David L Scott. (2012) Drug therapy of inflammatory arthritis. Clinical Medicine 12:4, pages 357-363.
Crossref
James H. Lewis. (2012) Clinical Perspective: Statins and the Liver—Harmful or Helpful?. Digestive Diseases and Sciences 57:7, pages 1754-1763.
Crossref
Ottar M. Bergmann, Gudjon Kristjansson, Jon G. Jonasson & Einar S. Björnsson. (2011) Jaundice Due to Suspected Statin Hepatotoxicity: A Case Series. Digestive Diseases and Sciences 57:7, pages 1959-1964.
Crossref
William M. Lee. 2012. Goldman's Cecil Medicine. Goldman's Cecil Medicine 979 984 .
Herbert L. Bonkovsky, Dean P. Jones, Mark W. Russo & Steven I. Shedlofsky. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 417 461 .
Alexander Brack & Michael Schäfer. 2012. Die Anästhesiologie. Die Anästhesiologie 251 272 .
Nicola J. Gullick & David L. Scott. (2011) Co-morbidities in established rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 25:4, pages 469-483.
Crossref
R. J. Andrade & P. M. Tulkens. (2011) Hepatic safety of antibiotics used in primary care. Journal of Antimicrobial Chemotherapy 66:7, pages 1431-1446.
Crossref
G P Aithal, P B Watkins, R J Andrade, D Larrey, M Molokhia, H Takikawa, C M Hunt, R A Wilke, M Avigan, N Kaplowitz, E Bjornsson & A K Daly. (2011) Case Definition and Phenotype Standardization in Drug-Induced Liver Injury. Clinical Pharmacology & Therapeutics 89:6, pages 806-815.
Crossref
David E. Kleiner. 2011. Practical Hepatic Pathology: A Diagnostic Approach. Practical Hepatic Pathology: A Diagnostic Approach 311 352 .
Sarah J. Mitchell & Sarah N. HilmerAssociateAssociate. (2010) Drug-induced liver injury in older adults. Therapeutic Advances in Drug Safety 1:2, pages 65-77.
Crossref
Adrian Reuben, David G. Koch & William M. Lee. (2010) Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study. Hepatology 52:6, pages 2065-2076.
Crossref
Ayako Suzuki, Raul J. Andrade, Einar Bjornsson, M. Isabel Lucena, William M. Lee, Nancy A. Yuen, Christine M. Hunt & James W. Freston. (2010) Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™. Drug Safety 33:6, pages 503-522.
Crossref
STEPHEN H. ZINNER & KENNETH H. MAYER. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 475 486 .
Weida Tong, Qiang Shi, William Salminen, Minjun Chen, Hong Fang, Ayako Suzuki & Donna L. Mendrick. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Ayse L. Mindikoglu, Laurence S. Magder & Arie Regev. (2009) Outcome of liver transplantation for drug-induced acute liver failure in the United States: Analysis of the united network for organ sharing database. Liver Transplantation 15:7, pages 719-729.
Crossref
K. N. Woodward. 2009. Veterinary Pharmacovigilance. Veterinary Pharmacovigilance 423 452 .
Rosalind E. Jenkins, Xiaoli Meng, Victoria L. Elliott, Neil R. Kitteringham, Munir Pirmohamed & B. Kevin Park. (2009) Characterisation of flucloxacillin and 5‐hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo . PROTEOMICS – Clinical Applications 3:6, pages 720-729.
Crossref
Loren Laine, Lawrence Goldkind, Sean P Curtis, Laurine G Connors, Zhang Yanqiong & Christoper P Cannon. (2009) How Common Is Diclofenac-Associated Liver Injury? Analysis of 17,289 Arthritis Patients in a Long-Term Prospective Clinical Trial. The American Journal of Gastroenterology 104:2, pages 356-362.
Crossref
Kay Brune, Burkhard Hinz & Ivan Otterness. (2009) Aspirin and acetaminophen: Should they be available over the counter?. Current Rheumatology Reports 11:1, pages 36-40.
Crossref
PAULETTE BIOULAC-SAGE & CHARLES BALABAUD. 2009. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas 1059 1086 .
Bénédicte Lebrun-Vignes. 2009. Life-Threatening Dermatoses and Emergencies in Dermatology. Life-Threatening Dermatoses and Emergencies in Dermatology 267 276 .
E. Björnsson. (2008) Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica 118:5, pages 281-290.
Crossref
Mary Lynn Bajt, Hui-Min Yan, Anwar Farhood & Hartmut Jaeschke. (2008) Plasminogen Activator Inhibitor-1 Limits Liver Injury and Facilitates Regeneration after Acetaminophen Overdose. Toxicological Sciences 104:2, pages 419-427.
Crossref
Elizabeth J. Carey, Hugo E. Vargas, David D. Douglas, Vijayan Balan, Thomas J. Byrne, M. Edwyn Harrison & Jorge Rakela. (2008) Inpatient Admissions for Drug-induced Liver Injury: Results from a Single Center. Digestive Diseases and Sciences 53:7, pages 1977-1982.
Crossref
Craig Lammert, Stefan Einarsson, Chandan Saha, Anna Niklasson, Einar Bjornsson & Naga Chalasani. (2008) Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals. Hepatology 47:6, pages 2003-2009.
Crossref
U. Hartmann, S. Schmitt & M. Reuss-Borst. (2008) Leberwerterhöhung bei rheumatoider ArthritisElevated liver enzymes in rheumatoid arthritis. Zeitschrift für Rheumatologie.
Crossref
Payam Eghtesadi-Araghi, Amir-Ali Sohrabpour, Homayoon Vahedi & Mehdi Saberi-Firoozi. (2008) Halothane hepatitis in Iran: A review of 59 cases. World Journal of Gastroenterology 14:34, pages 5322.
Crossref
Micaela C. Damsten, Barbara M.A. van Vugt-Lussenburg, Tineke Zeldenthuis, Jon S.B. de Vlieger, Jan N.M. Commandeur & Nico P.E. Vermeulen. (2008) Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Chemico-Biological Interactions 171:1, pages 96-107.
Crossref
Natascia Corti & Alexander Imhof. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 297 315 .
Hanns-Ulrich Marschall, Martin Wagner, Gernot Zollner & Michael Trauner. (2007) Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors. Molecular Pharmaceutics 4:6, pages 895-910.
Crossref
Sergio Negrin Dastis, Jacques Rahier, Jan Lerut & André P. Geubel. (2007) Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. European Journal of Gastroenterology & Hepatology 19:11, pages 919-922.
Crossref
Guruprasad P. Aithal & Christopher P. Day. (2007) Nonsteroidal Anti-Inflammatory Drug–Induced Hepatotoxicity. Clinics in Liver Disease 11:3, pages 563-575.
Crossref
Nigel Kirkham & Neil A. ShepherdSusan E. Davies & Clare Craig. 2010. Progress in Pathology. Progress in Pathology 247 270 .
Ann K. Daly, Guruprasad P. Aithal, Julian B.S. Leathart, Richard A. Swainsbury, Tarana Singh Dang & Christopher P. Day. (2007) Genetic Susceptibility to Diclofenac-Induced Hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 Genotypes. Gastroenterology 132:1, pages 272-281.
Crossref
M. B. DE VALLE, V. AV KLINTEBERG, N. ALEM, R. OLSSON & E. BJÖRNSSON. (2006) Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic. Alimentary Pharmacology & Therapeutics 24:8, pages 1187-1195.
Crossref
Einar Björnsson, Hans Nordlinder & Rolf Olsson. (2006) Clinical characteristics and prognostic markers in disulfiram-induced liver injury. Journal of Hepatology 44:4, pages 791-797.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.